Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 5
1971 3
1972 2
1973 1
1974 1
1976 1
1977 1
1978 2
1979 2
1980 2
1981 3
1982 4
1984 1
1985 1
1986 1
1987 3
1988 9
1989 4
1990 3
1991 5
1992 2
1994 4
1995 5
1996 4
1997 3
1999 2
2000 1
2001 1
2002 2
2004 1
2011 1
2012 1
2013 3
2014 5
2015 6
2016 17
2017 9
2018 2
2019 2
2020 5
2021 3
2022 13
2023 25
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Lung cancer progression alters lung and gut microbiomes and lipid metabolism.
Hagihara M, Kato H, Yamashita M, Shibata Y, Umemura T, Mori T, Hirai J, Asai N, Mori N, Mikamo H. Hagihara M, et al. Among authors: hirai j. Heliyon. 2023 Dec 9;10(1):e23509. doi: 10.1016/j.heliyon.2023.e23509. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38169741 Free PMC article.
Clinical characteristics and antimicrobial susceptibility of Fusobacterium species isolated over 10 years at a Japanese university hospital.
Mori N, Nakamura A, Hirai J, Asai N, Shibata Y, Takayama M, Kawamoto Y, Miyazaki N, Sakanashi D, Ohno T, Yamada A, Suematsu H, Koita I, Chida S, Ohta T, Mikamo H. Mori N, et al. Among authors: hirai j. Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):423-433. doi: 10.1007/s10096-023-04734-2. Epub 2023 Dec 19. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38112966
Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan.
Hirai J, Mori N, Sakanashi D, Ohashi W, Shibata Y, Asai N, Kato H, Hagihara M, Mikamo H. Hirai J, et al. Viruses. 2023 Sep 19;15(9):1952. doi: 10.3390/v15091952. Viruses. 2023. PMID: 37766358 Free PMC article.
170 results